Faculty who have authored publication Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
Name | Title | Department | Institution |
---|---|---|---|
Stuart J. Wong MD | Center Director, Professor | Medicine | Medical College of Wisconsin |